BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Approvals
Aqua Pharmaceuticals Announces FDA Approval Of ACTICLATE™ (Doxycycline Hyclate USP) Tablets, 150 Mg And 75 Mg 7/28/2014
FDA Approves Purdue Pharma L.P.’s Hard-to-Abuse Narcotic Painkiller 7/28/2014
U.S. FDA Grants Regular (Full) Approval For Pharmacyclics, Inc. (PCYC)'s IMBRUVICA® For Two Indications 7/28/2014
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use 7/23/2014
U.S. Gilead Sciences, Inc. (GILD) Approves FDA's Zydelig® (idelalisib) For Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma 7/23/2014
FDA Approves Eagle Pharmaceuticals (EGRX)' Ryanodex® For The Treatment Of Malignant Hyperthermia 7/23/2014
Starpharma: VivaGel® Condom Receives TGA Device Certification - Launch Preparations To Follow 7/21/2014
Pharming Group (PHGUF.PK), Salix Pharmaceuticals, Ltd. (SLXP) Wins FDA Approval For Ruconest® 7/17/2014
Purdue Pharma L.P. Receives FDA Approval For 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII 7/16/2014
Hamilton Thorne, Inc. Receives Notification Of Grant Of Patent Right And CFDA Approval To Market Its LYKOS(R) Laser System In China 7/16/2014
MediWound (MDWD) Announces NexoBrid Marketing Approval From Israeli Ministry of Health 7/16/2014
Ion Beam Applications (IBA) Receives FDA Approval Of Its New Compact Gantry Clearing The Way For Proteus®ONE 7/16/2014
Octapharma USA, Inc. Announces FDA Approval Of Octagam 10%, Expanding Its Immune Globulin Therapy Portfolio 7/15/2014
Medac Pharma, Inc. Wins FDA Approval Of Rasuvo Injection For Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis 7/14/2014
Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval Of APTIOM(TM) (eslicarbazepine acetate) As A Once-Daily Adjunctive Treatment For Partial-Onset Seizures In Patients With Epilepsy 7/11/2014
Can-Fite BioPharma (CFBI)'s CF102 Approved For Compassionate Use In Israel For Liver Cancer Patient 7/10/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: Swissmedic Approves AMITIZA® (Lubiprostone) For The Treatment Of Opioid-Induced Constipation 7/8/2014
FDA Approves Anacor Pharmaceuticals, Inc. (ANAC)’ KERYDIN™ (Tavaborole) Topical Solution, 5% For The Treatment Of Onychomycosis Of The Toenails 7/8/2014
Protein Sciences Corporation Receives Approval From FDA For 2014/15 Formulation Of Flublok® Influenza Vaccine 7/8/2014
Japan Becomes First Country To Approve Roche (RHHBY)'s Alectinib For People With A Specific Form Of Advanced Lung Cancer 7/7/2014
BioMarin Pharmaceutical Inc. (BMRN) Announces Health Canada Approval Of VIMIZIM™ (elosulfase alfa) For The Treatment Of Morquio A Syndrome 7/7/2014
Bristol-Myers Squibb Company (BMY) Release: Japan Approves First All-Oral, Interferon- And Ribavirin-Free Hepatitis C Treatment, Daklinza® (Daclatasvir) And Sunvepra®(Asunaprevir) Dual Regimen 7/7/2014
Theravance, Inc. (THRX) Release: Anoro® Ellipta® (Umeclidinium/Vilanterol) Gains Approval In Japan For The Treatment Of COPD 7/7/2014
FDA Approves Novo Nordisk A/S (NVO)'s NovoSeven® RT To Treat Glanzmann's Thrombasthenia (GT) With Refractoriness 7/7/2014
FDA Green Lights Spectrum Pharmaceuticals, Inc. (SPPI)'s Beleodag To Treat Rare Form Of Lymphoma 7/3/2014
FDA Approves MannKind Corporation (MNKD)'s Much Anticipated Diabetes Therapy Afrezza 7/1/2014
Genzyme Corporation (GENZ)’s Lemtrada Approved In Argentina For Treatment Of Multiple Sclerosis 6/30/2014
Flamel Technologies (FLML) Wins FDA Approval For VAZCULEP 6/30/2014
pSivida Corp (PSDV)'s Iluvien Gets Marketing Authorizations In 10 More EU Countries 6/30/2014
India's Ranbaxy Laboratories (RANBAXY.BO) Wins FDA Approval For Novartis AG (NVS)'s Diovan Generic 6/27/2014
Paragon BioTeck Grabs FDA Approval For Comfortear Lacrisolve Absorbable Punctum Plug 6/26/2014
Intuitive Surgical, Inc. (ISRG) Receives CE Mark For The Da Vinci® Xi™ Surgical System 6/25/2014
NeuroMetrix, Inc. (NURO) Reports Japan Regulatory Approval For NC-stat DPNCheck 6/24/2014
Hengrui Medicine Granted Approval To Market Cancer Drug In U.S. 6/24/2014
Cubist Pharmaceuticals, Inc. (CBST) Wins FDA Approval For MRSA Antibiotic Sivextro 6/24/2014
Rockwell Medical (RMTI) Receives FDA Approval For Calcitriol 6/23/2014
Roche (RHHBY) Medicine Gazyvaro Granted Approval For The Therapy Of Patients With Previously Untreated Chronic Lymphocytic Leukemia And Co-Existing Medical Conditions In Switzerland 6/18/2014
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In Europe For The Prevention Of Anal Cancer 6/18/2014
Valeant Pharmaceuticals International (VRX) Receives U.S. FDA Clearance For Restylane® Silk 6/17/2014
Navidea Biopharmaceuticals (NAVB) Release: FDA Approves Lymphoseek To Help Determine The Extent Of Head And Neck Cancer In The Body 6/13/2014
Breckenridge Pharmaceutical, Inc. Announces Approval For Duloxetine Delayed-Release Capsules 6/13/2014
FDA Approves Bayer HealthCare (BAY)'s Gadavist (Gadobutrol) Injection As The First Magnetic Resonance Contrast Agent For Evaluation Of Breast Cancer In The United States 6/12/2014
FDA Green Lights Strativa Pharmaceuticals' Nascobal® (Cyanocobalamin, USP) Nasal Spray Single-Use Device 6/11/2014
Acella Pharmaceuticals, LLC Announces Approval Of Tranexamic Acid Injection 6/10/2014
North Carolina's BioDelivery Sciences International (BDSI) Wins FDA Approval For Opiod Dependence Drug Bunavail 6/10/2014
FDA Approves Valeant Pharmaceuticals International (VRX) Toenail Fungus Drug Jublia® 6/9/2014
FDA Approves Biogen, Inc.'s Hemophilia A Drug Eloctate 6/9/2014
Teva Pharmaceutical Industries Limited (TEVA): FDA Clears Expanded Label For AZILECT® For Treatment Across All Stages Of Parkinson's Disease 6/9/2014
Boehringer Ingelheim Corporation's Pradaxa® Wins EU Approval To Treat Deep Vein Thrombosis And Pulmonary Embolisms 6/6/2014
Janssen-Cilag International NV Release: INVEGA® Receives European Commission Approval To Extend Its Adult Indication For Treatment Of Schizophrenia To Include Adolescents Aged 15 Years And Older 6/4/2014
Omeros Corporation (OMER) Receives FDA Approval Of Omidria™ For Use In Cataract And Other Intraocular Lens Replacement Procedures 6/2/2014
Bayer HealthCare (BAY) Receives EU Approval For Nexavar (Sorafenib) For The Treatment Of Differentiated Thyroid Cancer 5/30/2014
Protalix Biotherapeutics, Inc. (PLX) Announces ELELYSO™ (Taliglucerase Alfa) Approved In Canada For The Treatment Of Gaucher Disease In Both Adult And Pediatric Patients 5/30/2014
Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) (TRL.TO) Rises On FDA Approval For Natesto™ Nasal Gel 5/29/2014
FDA Green Lights Eisai Inc. (ESALF.PK)'s ALOXI ®To Prevent Nausea And Vomiting Due To Chemotherapy In Kids 5/29/2014
Nuvo Research Inc. (NRI.TO) Announces FDA Approval Of Third-Party Generic Of PENNSAID 1.5% 5/29/2014
Amgen (AMGN) Colorectal Cancer Drug Vectibix Gains Expanded Approval From The FDA 5/28/2014
FDA Approves Durata Therapeutics, Inc.  (DRTX)'s Dalvance To Treat Skin Infections 5/28/2014
Janssen Inc.'s First-In-Class Type 2 Diabetes Medication Approved In Canada 5/27/2014
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Approval For QVAR® 5/27/2014
European Commission (EC) Approves Boehringer Ingelheim Corporation-Eli Lilly and Company (LLY)'s Jardiance® Tablets 5/23/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Entyvio Wins FDA Approval For Severe Colitis 5/22/2014
Protalix Biotherapeutics, Inc. (PLX) Announces ELELYSO™ (Taliglucerase Alfa) Approved In Australia For The Treatment Of Gaucher Disease In Both Adult And Pediatric Patients 5/22/2014
Merck Animal Health Announces FDA Approval Of BRAVECTO™ (fluralaner) 5/20/2014
Novartis AG (NVS) Release: First Myelofibrosis Medication For Life-Threatening Blood Cancer Approved In Singapore 5/15/2014
Actavis (ACT) Receives Final Approval For Generic Version Of Exalgo® 5/14/2014
Merck & Co., Inc. (MRK) Release: FDA Approves ZONTIVITY™ (Vorapaxar), First-In-Class PAR-1 Antagonist, For The Reduction Of Thrombotic Cardiovascular Events In Patients With A History Of Heart Attack Or With Peripheral Arterial Disease 5/12/2014
FDA Green Lights Novel Merck & Co., Inc. (MRK) Drug To Prevent Heart Attacks And Strokes 5/12/2014
Perrigo Company (PRGO) Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray 5/12/2014
FDA Approves Bayer HealthCare (BAY)'s Kogenate® FS Antihemophilic Factor VIII (Recombinant) For Routine Prophylaxis In Adults With Hemophilia A 5/12/2014
FDA Approves Genentech (RHHBY) And Novartis AG (NVS)'s Xolair For Treatment Of Chronic Hives 5/8/2014
AstraZeneca PLC (AZN) Gets A Lift In Pfizer Inc. (PFE) Fight As FDA Approves Heart Pill Epanova 5/7/2014
TNI BioTech Obtains Drug Approval For Sale Of Low Dose Naltrexone (LDN) From Government Of Malawi 5/6/2014
Alexion Pharmaceuticals Inc. (ALXN) Wins FDA Approval Of Soliris® Accelerated Approval To Regular Approval 5/6/2014
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)'s SYNRIBO® For Injection For Home Administration 5/5/2014
FDA Approves Ibalizumab Manufactured By WuXi PharmaTech Co., Ltd. For Treatment Of Patients On Expanded Access 5/5/2014
FDA Approves GlaxoSmithKline (GSK)'s COPD Drug Incruse™ Ellipta® 5/2/2014
Novartis AG (NVS) Gains FDA Approval For Lung Cancer Drug Zykadia™ 5/1/2014
Health Canada Approves EGRIFTA™ (Tesamorelin For Injection) And Theratechnologies Inc. (TH.TO) Regains Canadian Commercialization Rights To EGRIFTA™ 4/30/2014
FDA Green Lights Rare Disease Therapeutics, Inc.'s New Liquid Form To Treat Patients With Acute Lymphoblastic Leukemia (ALL) 4/30/2014
BioMarin Pharmaceutical Inc. (BMRN) Announces European Commission Approval For VIMIZIM® (Elosulfase Alfa) For The Treatment Of Morquio A Syndrome In Patients Of All Ages 4/28/2014
Janssen-Cilag International NV (JNJ) Release: VOKANAMET® (Canagliflozin And Immediate Release Metformin Hydrochloride Fixed Dose Combination) Approved In The European Union For Treatment Of Adults With Type 2 Diabetes [1] 4/25/2014
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Spain 4/24/2014
Sunascen Therapeutics Gets FDA's Green Light For The New Over-The-Counter NAUS-EASE® Tablets 4/24/2014
FDA Approves Janssen Biotech Inc. (JNJ)'s SYLVANT™ For Rare Castleman's Disease 4/24/2014
Baxter International, Inc. (BAX) Announces FDA Approval Of ADVATE (Antihemophilic Factor [Recombinant]) With BAXJECT III Reconstitution System 4/23/2014
FDA Approves Eli Lilly and Company (LLY)'s Cyramza For Stomach Cancer 4/23/2014
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Wins FDA Approval For Arzerra As First-Line Treatment For Chronic Lymphocytic Leukaemia (CLL) 4/18/2014
FDA OKs Merck & Co., Inc. (MRK) Tablet To Reduce Ragweed Allergies 4/18/2014
GlaxoSmithKline (GSK) Announces Approval In Canada For Incruse™ Ellipta™ (Umeclidinium) As A Treatment For COPD 4/17/2014
FDA Approves GlaxoSmithKline (GSK)'s Tanzeum To Treat Type 2 Diabetes 4/15/2014
FDA Approves Merck & Co., Inc. (MRK)'s Grass Pollen Pill GRASTEK® 4/15/2014
Par Pharmaceutical, Inc. Begins Shipment Of Potassium Chloride Extended-Release Capsules 4/8/2014
Teva Pharmaceutical Industries Limited (TEVA) First Approval And Launch Of Generic Lovaza® Capsules In The United States 4/8/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Release: FDA Approves Pradaxa® (Dabigatran Etexilate Mesylate) For Treatment And Reduction In The Risk Of Recurrence Of Deep Venous Thrombosis And Pulmonary Embolism 4/7/2014
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In The European Union For A 2-Dose Schedule In Children Aged From 9 To 13 Years 4/7/2014
Dyax Corp. (DYAX) Receives FDA Approval To Expand Use Of KALBITOR® (Ecallantide) For The Treatment Of Acute Attacks Of Hereditary Angioedema To Patients 12 Years Of Age And Older 4/4/2014
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Luxembourg 4/3/2014
FDA Approves Kaleo's Hand-Held Auto-Injector To Reverse Opioid Overdose 4/3/2014
Stallergenes, S.A. (GENP.PA) Wins FDA's Go-Ahead For Oralair Allergy Pill 4/2/2014
FDA Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Hemophilia B Drug Alprolix 3/31/2014
FDA OKs Janssen Pharmaceutical Inc. 's Topamax For Migraine Prevention In Adolescents 3/31/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets Approval For Influenza Vaccines 3/31/2014
Pfizer Inc. (PFE) Statement On FDA Approval Of Over-the-Counter Nexium® 24HR 3/31/2014
Swedish Orphan Biovitrum: FDA Approves Alprolix™ 3/31/2014
European Commission (EC) Approves Roche (RHHBY)'s New Formulation Of Blood Cancer Drug 3/28/2014
Bay Area's Exelixis, Inc. (EXEL) Gets A Boost, Wins Approval For COMETRIQ® In European Union For Treatment Of MTC 3/27/2014
GlaxoSmithKline (GSK)'s Type 2 Diabetes Drug Eperzan® Wins EU Approval 3/27/2014
Actavis (ACT) And Valeant Pharmaceuticals International (VRX) Announce FDA Approval For Metronidazole 1.3% 3/26/2014
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014
Celgene Corporation (CELG) Wins FDA Approval For Pill To Treat Psoriatic Arthritis 3/25/2014
Novartis AG (NVS) Announces FDA Approval Of Xolair® (Omalizumab) For Chronic Idiopathic Urticaria (CIU), A Form Of Chronic Hives 3/24/2014
Taiho Pharmaceutical's Lonsurf® (Trifluridine And Tipiracil Hydrochloride) Tablets Approved In Japan For Treatment Of Advanced Metastatic Colorectal Cancer 3/24/2014
Health Canada Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Long-Acting ALPROLIX™ Therapy For Hemophilia B 3/24/2014
Otsuka Pharmaceutical Co., Ltd.'s Samsca® Approved In Japan As The World's First Drug Therapy For ADPKD, A Rare Kidney Disease 3/24/2014
Medivir AB (MVRBF): Simeprevir Has Now Been Approved In Russia 3/24/2014
Genzyme Corporation (GENZ)'s Lemtrada™ Approved In Brazil For Treatment Of Multiple Sclerosis 3/21/2014
Health Canada Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Long-Acting ALPROLIX™ Therapy For Hemophilia B 3/21/2014
Health Canada Approves Swedish Orphan Biovitrum's Alprolix™ 3/21/2014
Knight Therapeutics Announces FDA Approval For Impavido® (Miltefosine) For The Treatment Of Visceral, Mucosal And Cutaneous Leishmaniasis 3/20/2014
Ferring Pharmaceuticals Receives FDA Approval For The First And Only Mixed Protocol IVF Treatment -- Combines MENOPUR® (Menotropins For Injection) And BRAVELLE® (Urofollitropin For Injection, Purified) In Single Syringe 3/19/2014
Pierre Fabre Obtains FDA Approval To Market Hemangeo™ For The Treatment Of Infantile Hemangioma 3/18/2014
Starpharma Holdings Ltd Release: Vivagel®-Coated Condom Approved For Marketing In Japan 3/14/2014
Bristol-Myers Squibb Company (BMY)/Pfizer Inc. (PFE) Release: FDA Approves Eliquis® (Apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery 3/14/2014
Upsher-Smith Laboratories Receives FDA Approval For Qudexy™ XR (Topiramate) Extended-Release Capsules 3/13/2014
TaiGen Biotechnology Granted Taiwanese Approval For Novel Antibiotic 3/13/2014
Mallinckrodt Pharmaceuticals (MNK) Receives FDA Approval For XARTEMIS XR (Oxycodone Hydrochloride And Acetaminophen) Extended-Release Tablets (CII) 3/12/2014
Amerigen Pharmaceuticals Announces That Its ANDA For Carbidopa 25mg Tablets Has Received Final Approval From The FDA 3/12/2014
Northwest Biotherapeutics (NWBO) Jumps As Germany Permits Sale Of Brain Cancer Drug 3/11/2014
Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) Now Approved In Over 100 Countries For Stroke Prevention In Atrial Fibrillation 3/6/2014
FDA Approves Endo Pharmaceuticals (ENDP)'s Testosterone Drug AVEED™ 3/6/2014
AstraZeneca PLC (AZN) Wins FDA Approval For Bydureon® Pen 3/4/2014
Vectura Group plc (VEC.L): South Korean Regulatory Authority Confirm Approval Of AirFluSal® Forspiro® 2/28/2014
Oasmia Wins FDA Conditional Approval For Paccal Vet In Two Canine Cancers 2/28/2014
FDA Green Lights Anika Therapeutics (ANIK)'s Osteoarthritis Drug MONOVISC® Stock Surges +31.74% At 9:51AM ET On Wednesday 2/26/2014
FDA Approves Bristol-Myers Squibb Company (BMY)' Drug For Rare Fat Disorder 2/26/2014
Iroko Pharmaceuticals Receives FDA Approval For TIVORBEX™ 2/25/2014
Pfizer Inc. (PFE) Announces FDA Approval To Include Radiographic Data On Reduction Of Progression Of Structural Joint Damage For Adults With Moderately To Severely Active Rheumatoid Arthritis In Labeling For XELJANZ® (Tofacitinib Citrate) 2/24/2014
FDA Approves Vertex Pharmaceuticals (MA) (VRTX)'s KALYDECO™ (Ivacaftor) For Use In Eight Additional Mutations That Cause Cystic Fibrosis 2/24/2014
Oculus Innovative Sciences, Inc. (OCLS) Receives Approval For Oral And Throat Infection Products In Mexico 2/19/2014
FDA Approves Booming BioMarin Pharmaceutical Inc. (BMRN)'s VIMIZIM™ 2/19/2014
Chelsea Therapeutics, Inc. (CHTP) Pops As FDA Finally Approves NORTHERA™ 2/19/2014
BioDiem Ltd. (BDM.AX)'s Announcement Of Approval Of LAIV Seasonal Flu Vaccine In India 2/18/2014
Pharmacyclics, Inc. (PCYC)'s Imbruvica Wins Second Cancer Approval 2/13/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Full FDA Approval Of SYNRIBO® (Omacetaxine Mepesuccinate) For Injection 2/13/2014
The Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) Alliance Announces Once-Monthly (Pr)ABILIFY MAINTENA(™) (ARIPIPRAZOLE For Prolonged Release Injectable Suspension)1 Now Approved In Canada For The Maintenance Treatment Of Schizophrenia In Stabilized Adult Patients 2/13/2014
Aegerion Pharmaceuticals, Inc. (AEGR)' JUXTAPID(™) (Lomitapide) Capsules Approved In Canada For The Treatment Of Homozygous Familial Hypercholesterolemia (Hofh) 2/11/2014
Aegerion Pharmaceuticals, Inc. (AEGR)'s JUXTAPID™ (Lomitapide) Capsules Approved In Canada For The Treatment Of Homozygous Familial Hypercholesterolemia (Hofh) 2/10/2014
Vectura Group plc (VEC.L) Release: Norwegian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 2/10/2014
Genzyme Corporation (GENZ)’s Lemtrada® Approved In Mexico For Treatment Of Multiple Sclerosis 2/4/2014
Merck & Co., Inc. (MRK) Announces Canadian Approval Of GRASTEK® (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet) 2/3/2014
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Multiple Schlerosis Med TECFIDERA® Wins European Approval 2/3/2014
FDA Approves Vanda Pharmaceuticals, Inc. (VNDA)'s Sleep Disorder Drug HETLIOZ™ 2/3/2014
Valeant Pharmaceuticals International (VRX) Announces Approval Of Retin-A Micro® Microsphere 0.08% 1/31/2014
Acella Pharmaceuticals, LLC Announces Approval And Launch Of Loutrex Topical Cream 1/31/2014
Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs® CD34 Reagent System For Prevention Of Graft-Versus-Host Disease In The Treatment Of Acute Myeloid Leukemia 1/24/2014
Perrigo Company (PRGO) Receives FDA Final Approval For Generic Equivalent To Prandin® 1/24/2014
AstraZeneca PLC (AZN)'s Diabetes Drug Xigduo Approved In Europe 1/23/2014
Apricus Biosciences (APRI)Announces National Phase Approval For Erectile Dysfunction Cream - Vitaros® In Belgium 1/23/2014
Hi-Tech Pharmacal (HITK) Receives Final Approval For Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day) 1/23/2014
Aegerion Pharmaceuticals, Inc. (AEGR)'s JUXTAPID® Capsules Approved In Mexico 1/20/2014
FDA Approves Affymetrix (Santa Clara, California) (AFFX)'s First Of-Its-Kind Mental Disability Blood Test For Infants 1/20/2014
Keryx Biopharmaceuticals (KERX) Announces Marketing Approval Of Ferric Citrate In Japan 1/17/2014
Mallinckrodt Pharmaceuticals (MNK) Rises As New Drug App Is Approved By The FDA 1/17/2014
Vectura Group plc (VEC.L) Hungarian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/16/2014
Perrigo Company (PRGO) Announces FDA Final Approval for Generic Version of Vanos® (Fluocinonide) Cream 0.1% 1/15/2014
Novartis Pharmaceuticals Canada Inc. (NVS) Receives Health Canada Approval For Ultibro ™ Breezhaler ®, A Once-Daily Dual Bronchodilator For COPD 1/14/2014
Vectura Group plc (VEC.L) German Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/13/2014
AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY)'s New Approach Diabetes Drug, Farxiga™, Wins FDA Approval 1/10/2014
GlaxoSmithKline (GSK) Gains Accelerated FDA Approval For Combination Use Of Mekinist® (Trametinib) And Tafinlar® (Dabrafenib) 1/9/2014
Merck & Co., Inc. (MRK) Receives FDA Approval For ISENTRESS® (raltegravir) For Pediatric Oral Suspension 1/8/2014
Celgene International Sárl (CELG) Release: ABRAXANE® Plus Gemcitabine Receives European Marketing Authorization For First-Line Treatment Of Patients With Metastatic Pancreatic Cancer 1/7/2014
Lundbeck Inc. (LUN.CO) Wins EU Marketing Approval For Brintellix To Treat Adult Depression 1/3/2014
Innovus Pharma Announces Start Of Its Circumserum™ Commercial Phase In Morocco With Initial Order Of 10,000 Units By Its Partner OVATION Pharmaceuticals (Acquired by Lundbeck in March 2009) 12/27/2013
FDA Gives The Green Light To Novo Nordisk A/S (NVO)'s TRETTEN® For Rare Blood Clotting Disorder 12/27/2013
Supernus Pharmaceuticals (SUPN) Announces FDA Approval Of Its Partner's Product, Orenitram™ 12/27/2013
United Therapeutics Corporation (UTHR) Hits All-Time High As FDA OKs Lung Disease Drug; Stock Up +30.36% At Market Close (Dec. 23, 2013) 12/27/2013
Actelion Ltd. (ALIOF.PK)'s New Blood Pressure Drug Get EU Nod 12/23/2013
Biota Pharmaceuticals, Inc. Reports That Laninamivir Octanoate Is Approved For The Prevention Of Influenza In Japan 12/23/2013
Kanghong Pharma Gains CFDA Approval For China's First Innovative MAb 12/23/2013
EU Approves Merck KGaA (MKGAF.PK)'s Erbitux For A Subtype Of Cancer 12/23/2013
FDA Approves New Label Indications For Bayer HealthCare (BAY)'s Advantage Multi® (Imidacloprid + Moxidectin) In The U.S. 12/20/2013
Baxter International, Inc. (BAX) Completes CE Mark Approval For VIVIA Hemodialysis System In Europe 12/20/2013
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s Second Lung Drug ANORO™ ELLIPTA™ Wins FDA Approval 12/20/2013
Baxter International, Inc. (BAX) Receives FDA Approval Of FEIBA [Anti-Inhibitor Coagulant Complex] For Prophylactic Treatment Of Hemophilia A&B Patients With Inhibitors 12/19/2013
Genzyme Corporation (GENZ)'s Lemtrada™ Approved In Australia For Treatment Of Multiple Sclerosis 12/19/2013
Vectura Group plc (VEC.L): Danish Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 12/18/2013
CSL Behring's Kcentra® Receives FDA Approval For Use In Warfarin Reversal In Patients Undergoing Surgery 12/16/2013
FDA Approves Gilead Sciences, Inc. (GILD)'s Once-Daily Single Tablet HIV-1 Regimen 12/16/2013
Genzyme Corporation (GENZ)'s Lemtrada™ Approved In Canada For Treatment Of Multiple Sclerosis 12/13/2013
Eli Lilly and Company (LLY) Gets A Huge Blow As FDA OKs Cymbalta Generics 12/12/2013
FDA Approves Gilead Sciences, Inc. (GILD)'s Sovaldi™, A $1,000-A-Day Hepatitis C Pill 12/11/2013
Zogenix, Inc. Announces FDA Approval Of 4 Mg SUMAVEL® Dosepro® (Sumatriptan Injection) Needle-Free Delivery System 12/10/2013
Health Canada Approves Novartis Pharmaceuticals Canada Inc. (NVS)'s Bexsero*, The First Vaccine Available To Prevent Meningococcal Serogroup B (MenB)(1,2) 12/9/2013
AstraZeneca PLC (AZN)'s Fluenz Tetra Gets European Marketing Grant 12/6/2013
Innovus Pharma Receives Product License Approval Of Ejectdelay™ For Premature Ejaculation From Health Canada 12/6/2013
FDA Approves BioSpecifics Technologies Corporation (BSTC)'s First Drug Treatment For Peyronie's Disease 12/6/2013
European Medicines Agency Approves Once Every Two Weeks Dosing Option For CSL Behring UK Ltd's Hizentra® (Human Normal Immunoglobulin, SCIg) 12/5/2013
Bioniche Life Sciences Inc. (BNC) Horse Product Approved For Sale In The U.S. 12/2/2013
Fresenius Medical Care's Velphoro® (PA21) Receives FDA Approval 12/2/2013